These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9224984)

  • 41. Twenty-year follow-up of acquired renal cystic disease.
    Ishikawa I; Saito Y; Asaka M; Tomosugi N; Yuri T; Watanabe M; Honda R
    Clin Nephrol; 2003 Mar; 59(3):153-9. PubMed ID: 12653256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Normalization of hematocrit in regular hemodialysis patients: the role of renal cyst formation.
    Ono K; Kikawa K; Okamoto T; Matsuo H
    Trans Am Soc Artif Intern Organs; 1985; 31():639-43. PubMed ID: 3837523
    [No Abstract]   [Full Text] [Related]  

  • 43. Evaluation of acquired cystic kidney disease in patients on hemodialysis with ultrasonography.
    Beladi Mousavi SS; Sametzadeh M; Hayati F; Fatemi SM
    Iran J Kidney Dis; 2010 Jul; 4(3):223-6. PubMed ID: 20622311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Natural history of acquired renal cystic disease in dialysis patients: a prospective longitudinal CT study.
    Levine E; Slusher SL; Grantham JJ; Wetzel LH
    AJR Am J Roentgenol; 1991 Mar; 156(3):501-6. PubMed ID: 1899744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients.
    Movilli E; Cancarini GC; Zani R; Camerini C; Sandrini M; Maiorca R
    Nephrol Dial Transplant; 2001 Jan; 16(1):111-4. PubMed ID: 11209002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Statement on the clinical use of recombinant erythropoietin in anemia of end-stage renal disease. Ad Hoc Committee for the National Kidney Foundation.
    Am J Kidney Dis; 1989 Sep; 14(3):163-9. PubMed ID: 2672796
    [No Abstract]   [Full Text] [Related]  

  • 47. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac function and hematocrit level.
    Harnett JD; Kent GM; Foley RN; Parfrey PS
    Am J Kidney Dis; 1995 Apr; 25(4 Suppl 1):S3-7. PubMed ID: 7702071
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anemia: an early complication of chronic renal insufficiency.
    Kazmi WH; Kausz AT; Khan S; Abichandani R; Ruthazer R; Obrador GT; Pereira BJ
    Am J Kidney Dis; 2001 Oct; 38(4):803-12. PubMed ID: 11576884
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reasons for producing guidelines on anemia of chronic renal failure: dialysis outcome quality initiative of the National Kidney Foundation.
    Triolo G; Canavese C; Di Giulio S
    Int J Artif Organs; 1998 Nov; 21(11):751-6. PubMed ID: 9894755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of recombinant human erythropoietin on renal function in humans.
    Lim VS; Fangman J; Flanigan MJ; DeGowin RL; Abels RT
    Kidney Int; 1990 Jan; 37(1):131-6. PubMed ID: 2299799
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monitoring considerations in recombinant human erythropoietin therapy.
    Ogden DA
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):12-5. PubMed ID: 2669080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
    Dimković N
    Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improvement of nutritional status in patients receiving maintenance hemodialysis after correction of renal anemia with recombinant human erythropoietin.
    Tarng DC; Huang TP; Doong TI
    Nephron; 1998; 78(3):253-9. PubMed ID: 9546682
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcome data on pediatric dialysis patients from the end-stage renal disease clinical indicators project.
    Brem AS; Lambert C; Hill C; Kitsen J; Shemin DG
    Am J Kidney Dis; 2000 Aug; 36(2):310-7. PubMed ID: 10922309
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anemia and hypoalbuminemia at initiation of hemodialysis as risk factor for survival of dialysis patients.
    Anees M; Ibrahim M
    J Coll Physicians Surg Pak; 2009 Dec; 19(12):776-80. PubMed ID: 20042156
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acquired cystic disease of the kidneys in chronic hemodialyzed and renal transplant patients.
    Minar E; Tscholakoff D; Zazgornik J; Schmidt P; Marosi L; Czembirek H
    Eur Urol; 1984; 10(4):245-8. PubMed ID: 6383838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renal imaging in long-term dialysis patients: a comparison of CT and sonography.
    Taylor AJ; Cohen EP; Erickson SJ; Olson DL; Foley WD
    AJR Am J Roentgenol; 1989 Oct; 153(4):765-7. PubMed ID: 2672736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.